Clinical and immunologic evaluation of neuraminidase-specific influenza A virus vaccine in humans.
about
Vaccines for preventing influenza in healthy childrenVaccines for preventing influenza in healthy childrenVaccines for preventing influenza in healthy childrenPolarizing T and B Cell Responses by APC-Targeted Subunit VaccinesMolecular basis for broad neuraminidase immunity: conserved epitopes in seasonal and pandemic H1N1 as well as H5N1 influenza virusesA miniaturized assay for influenza neuraminidase-inhibiting antibodies utilizing reverse genetics-derived antigensRationale for treating human influenza infections by passive transfer of specific antibodies.An Intranasal Virus-Like Particle Vaccine Broadly Protects Mice from Multiple Subtypes of Influenza A Virus.Comparative Efficacy of Monoclonal Antibodies That Bind to Different Epitopes of the 2009 Pandemic H1N1 Influenza Virus Neuraminidase.The 2009 pandemic H1N1 virus induces anti-neuraminidase (NA) antibodies that cross-react with the NA of H5N1 viruses in ferretsA high dosage influenza vaccine induced significantly more neuraminidase antibody than standard vaccine among elderly subjects.In the shadow of hemagglutinin: a growing interest in influenza viral neuraminidase and its role as a vaccine antigen.Further studies of the neuraminidase content of inactivated influenza vaccines and the neuraminidase antibody responses after vaccination of immunologically primed and unprimed populationsCell-mediated immune responses to the hemagglutinin and neuraminidase antigens of influenza A virus after immunization in humansSerologic assays for influenza surveillance, diagnosis and vaccine evaluation.Immunization with purified N1 and N2 influenza virus neuraminidases demonstrates cross-reactivity without antigenic competition.Purified viral neuraminidase vaccine to control influenza.Optimization of an enzyme-linked lectin assay suitable for rapid antigenic characterization of the neuraminidase of human influenza A(H3N2) viruses.Contribution of antibody production against neuraminidase to the protection afforded by influenza vaccines.Randomized comparative study of the serum antihemagglutinin and antineuraminidase antibody responses to six licensed trivalent influenza vaccines.Purified influenza virus hemagglutinin and neuraminidase are equivalent in stimulation of antibody response but induce contrasting types of immunity to infection.Isolation of immunogenic neuraminidases of human influenza viruses by a combination of genetic and biochemical proceduresInfluenza vaccines: T-cell responses deserve more attention.Immunological assessment of influenza vaccines and immune correlates of protection.Neuraminidase-specific antibody responses to inactivated influenza virus vaccine in young and elderly adults.Seroprevalence of subtype H3 influenza A virus in South Korean cats.Recent contributions of molecular biology to the clinical virology of myxoviruses.Hemagglutinin and neuraminidase specific cell-mediated immune responses to influenza A virus following immunization in guinea pigs.Vaccines for preventing influenza in healthy children
P2860
Q24201525-4D97B669-F8F0-42E4-BEDE-21CFDFF4D574Q24243174-BF217099-CF2A-4B16-9F74-9B9423DE0913Q24244954-116A32DC-93F5-402A-B776-878AC36E75DDQ26800145-868E71B7-0A53-4D22-829B-351BE9E28F59Q28387782-72F761FD-5213-41D2-B4DF-F37C6DF60020Q28830491-24A42E61-64FA-487E-B43B-5CAC84A52B90Q30230073-4FB6A896-CE4C-491F-90AE-1C6F826A1A12Q30377023-4BCBBC93-1D63-4108-8230-D4ED370CC8D4Q30380287-4AA85E22-3F4D-48CD-9379-ED4E65445D9BQ30413023-3448D04D-A667-4C11-A24B-0BB11F0E502CQ33782762-F1FD76F4-35B9-4195-BCB8-8B5558A2061AQ33820732-7C21B1C7-D97F-452C-A164-6027F606812BQ33907707-13416EDE-CF8A-4A2C-9E01-DCA5693DCAA7Q34087792-79B38443-4203-49EA-86F2-A3D9541EF3F1Q34194336-941616EE-05CB-46E6-8AAC-B61ACB5D50B7Q35109380-0D324B9D-7102-4557-A843-45D90A4E7C73Q35228549-B6E5D61A-AA1D-4257-A601-9F083A35FFD6Q35235777-76F75BAE-EF0A-47A6-A03D-53CF9AF1263BQ36075789-133B640D-024E-474F-B3B0-01CCA20720FBQ36462309-0AF88E7B-45F1-4EDA-A2FC-0DDEED863A44Q36781677-35C2F817-EE83-44BE-A4F2-9AFBC004EFC4Q37266550-A5400F74-74F1-4548-8E07-C31AA742F02DQ38045918-65B6FF03-60E5-43EB-8D6D-0C540DB11F76Q38105339-77C8E79F-0627-4983-9D8A-DF9DB8643603Q39810755-C3F406EC-BE4F-46AF-B124-9830D6EF27EDQ40046280-9F5A2E16-1BFC-4423-929C-076304E13627Q41199980-FC8B8B96-5071-4D9F-BCE3-D5E4FD27A818Q45805973-D02472DC-2BAB-441A-A84A-6240DC3E3CABQ57272289-7463D725-F3F8-4B81-8697-782844233CAF
P2860
Clinical and immunologic evaluation of neuraminidase-specific influenza A virus vaccine in humans.
description
1977 nî lūn-bûn
@nan
1977年の論文
@ja
1977年学术文章
@wuu
1977年学术文章
@zh-cn
1977年学术文章
@zh-hans
1977年学术文章
@zh-my
1977年学术文章
@zh-sg
1977年學術文章
@yue
1977年學術文章
@zh
1977年學術文章
@zh-hant
name
Clinical and immunologic evalu ...... nza A virus vaccine in humans.
@en
type
label
Clinical and immunologic evalu ...... nza A virus vaccine in humans.
@en
prefLabel
Clinical and immunologic evalu ...... nza A virus vaccine in humans.
@en
P2093
P356
P1476
Clinical and immunologic evalu ...... nza A virus vaccine in humans.
@en
P2093
Beutner KR
Strussenberg J
P304
P356
10.1093/INFDIS/135.4.499
P407
P577
1977-04-01T00:00:00Z